Clinical Trials Directory

Trials / Terminated

TerminatedNCT02876770

Melatonin Supplementation and Performance

Nocturnal Melatonin Ingestion Ameliorates Short Term Maximal Performances on the Following Day

Status
Terminated
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
kais · Academic / Other
Sex
Male
Age
20 Years – 23 Years
Healthy volunteers
Accepted

Summary

The present study aimed to evaluate the possible effect of nocturnal melatonin ingestion upon short-term performances, on the following morning. Twelve soccer players from a Tunisian squad (22.9 ±1.3 years, 1.80±0.05 m, and 72.0±8.8 kg) were volunteered to perform three testing sessions, with one test session per day. During each session, MEL (5mg) , MEL (8mg) or placebo were ingested, in a randomized order, before nocturnal sleep. The next morning (08:00h), participants performed the following psycho-cognitive and physical tests: Hooper's index, reaction time, vigilance, handgrip strength , squat jump , modified agility test , Wingate anaerobic test (peak power , mean power and fatigue index ). Rating of perceived exertion was recorded immediately after the WanT, and blood lactate measures were taken after 3min of recovery. Blood glucose was measured before and 3 min after the Wingate test.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental: MelatoninOur protocol was composed of three experimental sessions. During each testing session, participants were requested to attend the laboratory at 20:00h where they ingested a standardized light meal. Melatonin (5 mg or 8 mg) or placebo were ingested in capsule in the evening at 21:00h in a double-blind randomized design
DIETARY_SUPPLEMENTPlaceboIn a double-blind randomized design, participants have taken placebo supplementation in one of the three experimental sessions

Timeline

Start date
2012-12-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2016-08-24
Last updated
2016-08-24

Source: ClinicalTrials.gov record NCT02876770. Inclusion in this directory is not an endorsement.